During the past decade, Sendai Medical Center conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 1 clinical trials were completed, i.e. on average, 14.3% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 1 clinical trials were completed. i.e. 20% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Sendai Medical Center" #1 sponsor was "Arena Pharmaceuticals" with 2 trials, followed by "Merck Sharp & Dohme LLC" with 2 trials sponsored, "AstraZeneca" with 1 trials sponsored, "Japan Clinical Cancer Research Organization" with 1 trials sponsored and "Pfizer" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Sendai Medical Center" #1 collaborator was "Arena is a wholly owned subsidiary of Pfizer" with 1 trials as a collaborator, "Taiho Pharmaceutical Co., Ltd." with 1 trials as a collaborator and "Tokyo Medical and Dental University" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Sendai Medical Center" are "Ulcerative Colitis" (3 trials), "Asthma" (1 trials), "Carcinoma, Non-squamous Non-small-cell Lung" (1 trials), "Carcinoma, Squamous Cell, Non-small-cell Lung" (1 trials) and "Colorectal Cancer" (1 trials). Many other conditions were trialed in "Sendai Medical Center" in a lesser frequency.

Most popular intervention types in "Sendai Medical Center" are "Drug" (8 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Etrasimod" (3 trials), "Placebo" (3 trials), "Carboplatin" (2 trials), "Olaparib" (2 trials) and "Pembrolizumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Sendai Medical Center" are 9 trials for "All" genders.

Currently, there are NaN active trials in "Sendai Medical Center". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Sendai Medical Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Sendai Medical Center, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".